1.Malignant Neurocutaneous Melanosis: A Case Report.
Tae Young KIM ; Kwang Soo OH ; Young Jin LEE ; Ki Jung YUN ; Jong Moon KIM
Journal of Korean Neurosurgical Society 2000;29(3):389-395
No abstract available.
Melanosis*
3.Diffuse Cutaneous Melanosis Associated with Malignant Melanoma.
Joanna MANGANA ; Lea FELDERER ; Phil CHENG ; Lars E FRENCH ; Reinhard DUMMER ; Karin SCHAD
Annals of Dermatology 2015;27(6):780-781
No abstract available.
Melanoma*
;
Melanosis*
5.Prevalence, epidemiology, and clinical characteristics of Melasma in Philippine dermatology patients: A multicenter, cross sectional study
Journal of the Philippine Dermatological Society 2019;28(1):15-23
Background:
Melasma is an acquired hyperpigmentary disorder occurring on sun-exposed areas of the face and
neck. There is little information on its prevalence, epidemiology and clinical characteristics in the Philippines.
Objective:
To determine the prevalence, epidemiology and clinical characteristics of melasma in Philippine
dermatology patients.
Methods:
This was a multicenter, cross-sectional study conducted from July to December 2013. The investigators
determined the prevalence of melasma in 12,068 dermatology patients from six government hospitals and private
clinics in Metro Manila, Philippines. The melasma patients, aged 18 years and above, were given self-administered
questionnaires with topics related to demographic information and medical history. They were also examined by
the investigators (dermatologists) to determine the clinical profile of their melasma.
Results:
Of the 12,068 dermatology patients who were seen at the selected hospitals and private clinics, 153 (1.26%)
were clinically diagnosed with melasma. A majority of the melasma patients were Filipinos (73.20%), aged 41-50
years old (37.91%), with an average age of 42.40 + 9.68 years, and Fitzpatrick skin types III and IV (29.41% and
57.52%, respectively). Melasma was more prevalent in females (81.70%), most of whom had prior history of
pregnancy (76.8%). Oral contraceptive use was also reported in 37.6% of the female patients from which 63.83%
have used it for only 1 year or less. A majority had no coexisting thyroid disease (75.16%) and daily sun exposure
was limited to 1 hour or less for most patients (43.14%). Their melasma was mostly malar in distribution (60.13%),
epidermal (61.44%), and mild (51.63%) to moderate (27.45%) in severity. The average mMASI score was 4.63 + 3.32.
Conclusion
The prevalence of melasma was low among Philippine dermatology patients sampled. A majority of the
melasma patients were Filipinos, aged 41-50 years old, with Fitzpatrick skin type IV, limited sun exposure, and no
coexisting thyroid disease. They were mostly females with a prior history of pregnancy. Their melasma was mostly
malar in location, epiderma type, and mild in severity. These descriptive data can serve as baseline information for
further studies on melasma in the Philippines.
Melanosis
;
Philippines
6.Possible Involvement of Keratinocyte Growth Factor in the Persistence of Hyperpigmentation in both Human Facial Solar Lentigines and Melasma.
Kiyotaka HASEGAWA ; Rumiko FUJIWARA ; Kiyoshi SATO ; Jaeyoung SHIN ; Sang Jin KIM ; Misun KIM ; Hee Young KANG
Annals of Dermatology 2015;27(5):626-629
No abstract available.
Fibroblast Growth Factor 7*
;
Humans*
;
Hyperpigmentation*
;
Keratinocytes*
;
Lentigo*
;
Melanosis*
7.Effective Treatment of Suspicious Riehl's Melanosis Using Low Fluence 1,064 nm Q-switched Nd:YAG Laser and 595 nm Pulsed Dye Laser.
Sung Kyu JUNG ; Jae Beom PARK ; Byoung Joon SO ; Jie Hyun JEON ; Hwa Jung RYU ; Il Hwan KIM
Korean Journal of Dermatology 2014;52(8):589-590
No abstract available.
Lasers, Dye*
;
Melanosis*
8.The evaluation on treatment results of melasma with hydroquinon
Journal of Practical Medicine 2004;478(4):57-58
30 patients aged 18-60 years old with melasma localized at the epiderm and epiderm plus mesoderm layer topically treated by 2% hydroquinone preparation within 6 months at the Venero-dermatol Institute were evaluated. Good and very good results reached in 42.5%. The size of lesion minimized by > 10% each months, especially 21% in the 2nd month. Mean size of lesion minimized by 75%. In 11.2% of patients, the size of lesion minimized by 90-100% and 56.3% of patients had got the lesion of 70-89% minimized size.
Therapeutics
;
Melanosis
;
Hydroquinones
9.Melasma Showing Response to Combination Therapy with Oral Tranexamic Acid and the Q-Switched Nd:YAG Laser.
Bum Joon KO ; Ga Hee JUNG ; Yung Lip PARK ; Jong Suk LEE ; Kyu Uang WHANG ; Sung Yul LEE
Korean Journal of Dermatology 2014;52(10):765-767
No abstract available.
Melanosis*
;
Tranexamic Acid*
10.Changes in Melanin and Melanocytes in Mottled Hypopigmentation after Low-Fluence 1,064-nm Q-Switched Nd:YAG Laser Treatment for Melasma.
Yong Hyun JANG ; Ji Youn PARK ; Young Joon PARK ; Hee Young KANG
Annals of Dermatology 2015;27(3):340-342
No abstract available.
Hypopigmentation*
;
Melanins*
;
Melanocytes*
;
Melanosis*